Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ranbaxy scientists describe new iminosugar-based anticancer agents

Oct. 19, 2004

Abarelix demonstrates safety and efficacy in clinical trials

Oct. 18, 2004

Vantas approved for advanced prostate cancer

Oct. 18, 2004

ArQule discovers oral B-RAF kinase inhibitors for oncology

Oct. 18, 2004

Antagonists of denatured collagen type IV and their use as antiangiogenic agents

Oct. 18, 2004

Nucleotide-bisphosphonate conjugates reduce metastatic bone tumor burden in mice

Oct. 18, 2004

Antiangiogenic small molecule inhibits VEGF production in tumors in vivo

Oct. 18, 2004

SB-715992 dose-dependently reduces ANC in patients with solid tumors

Oct. 15, 2004

Oral CP-547632 shows promise in the treatment of advanced solid tumors

Oct. 15, 2004

Aviscumine shows antitumor effects and a good safety profile in refractory cancer patients

Oct. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...